熱門資訊> 正文
Nutex Health报告第二季度业绩
2025-08-21 12:47
- Nutex Health press release (NASDAQ:NUTX): Q2 Revenue of $244M (+220.6% Y/Y) beats by $67.53M.
- Total visits at the Hospital Division were 45,573 for the three months ended June 30, 2025, as compared to 41,208 for the same period in 2024, an increase of 4,365 or 10.6%.
- Visits to mature hospitals increased by 0.6% in the three months ended June 30, 2025, as compared to the same period in 2024.
- For the three months ended June 30, 2025, the Company collected $175 million in cash, the highest collection amount for any quarter.
- Adjusted EBITDA was $71.6 million for the three months ended June 30, 2025, as compared to $6.8 million for the same period in 2024.
- Operating cash flow was $27.1 million for the three months ended June 30, 2025, as compared to $13.3 million for the same period in 2024.
More on Nutex Health
- Staying On The Sidelines With Nutex Health: Impressive Growth, Serious Doubts Remain
- Nutex Health: At An Inflection Point
- Nutex Health: Justified Dilution Given Explosive Growth In Free Cash Flow
- Nutex Health down on delayed Q2 financial statements
- Nutex Health reports Q2 results
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
